New EU Devices Regulation Lacking As A Safety And Effectiveness Check, German Study Claims
Executive Summary
Even though the new EU Medical Device Regulation marks a “very important advancement,” it still falls short when it comes to requirements on generating clinical evidence, according to a study conducted in Germany.
You may also be interested in...
EU's MDR: When Three Plus Four Does Not Necessarily Make Seven
Companies hoping to keep their medtech products certified under the current Medical Devices Directive on the market until May 2024 need a reality check, experts say. Things may not be as they seem.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.